Press Release: Bioceros - through its affiliated company BiocerOX Products and Janssen execute agreement to develop a monoclonal antibody. Utrecht, The Netherlands, January 8, 2014 Dutch Biotech company Bioceros today an - Janssen Biotech - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-01-08 02:14:10 Immune system Medicine Monoclonal antibodies Crucell Biologic Polyclonal antibodies Cambridge Antibody Technology Mogamulizumab Biology Immunology Biotechnology		Press Release: Bioceros - through its affiliated company BiocerOX Products and Janssen execute agreement to develop a monoclonal antibody. Utrecht, The Netherlands, January 8, 2014 Dutch Biotech company Bioceros today an Add to Reading List Source URL: www.bioceros.com Download Document from Source Website File Size: 57,37 KB Share Document on Facebook

	CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C DocID: 1lpEr - View Document
	High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology, DocID: 1kHcZ - View Document
	High throughput 96-well purification of biopharmaceuticals for cell-based screening Mike Jones, Debbie Pattison, Mark Liddament, John Andrews, Ruth Franks, Caroline Russell, Stephen Clulow Cambridge Antibody Technology, DocID: 1kF6v - View Document
	CHI’s Phage Display and Recombinant Antibodies Technology Poster, May 16-20, 2005, Cambridge, MA, Royal Sonesta Hotel Novel strategies for assaying recombinant antibody function with high-throughput cell-based assays C DocID: 1kyYE - View Document
	Tetragenetics Announces Collaboration with Amgen Exclusive Research License Of Tetragenetics’ Technology For Surface Antigen Drug Target CAMBRIDGE, Mass. April 2, 2013. Tetragenetics Inc. a 2012 Gates Foundation Phase DocID: 1a2GY - View Document